AEMPS Suspends Spanish Manufacturer’s License

International Pharmaceutical Regulatory Monitor
A A
Spain’s Agency of Medicines and Medical Devices has ordered Madrid vaccine maker Angulema to suspend manufacturing and recall drug batches over GMP deficiencies.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor